Skip to content
naulon

Not checkedNot checked for notices yet.

Assessment of the follow-up interval changes of the less than 2 cm arterial phase enhancing hepatic nodules in correlation with Liver Imaging Reporting and Data System (LI-RADS) classification version 18 using contrast-enhanced multidetector computed tomography

Sayed M. Mehana

The Egyptian Journal of Radiology and Nuclear Medicine · 2019

doi:10.1186/s43055-019-0068-x (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Abstract Background Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and the second leading cause of cancer death in the world. It is the only tumor that can be diagnosed by imaging only, without a need for histopathological confirmation. CT and MR are the imaging techniques that often allow making a definite diagnosis. This study is a prospective study done by multiphasic contrast-enhanced computed tomography on 25 patients with liver cirrhosis showing 30 hepatic arterial phase hyper-enhancing nodule. Follow-up CT studies for these nodules were performed 4 to 6 months after the initial study Results In the follow-up study, 14 (46.66%) lesions showed size progression; however, only 4 of them had a progression which was more than 50% (threshold progression as described in LI-RADS version18). Nine (30%) lesions showed stationary size, and 7 lesions (23.33%) disappeared. Regarding the enhancement dynamics, 2 lesions developed delayed non-rim washout. By application of the LI-RADS classification, LI-RADS 3 category was noted in 25 lesions, and only 2 lesions evolved in the follow-up to LI-RADS 5 (using version 17 of the LI-RADS), while using LI-RADS version 18, only 3 lesions evolved. Five lesions were classified as LI-RADS 4 category by LI-RADS version 20017, and all these lesions progressed in size with 2 of them (40%) exceeded the growth threshold in the follow-up and progressed to LI-RADS 5. Using version 18 of the LI-RADS system, these lesions are classified as LI-RADS 5 category in the initial study. Conclusion The findings of the current study support the modification of the LI-RADS scoring system in the LI-RADS version 2018 upgrading arterial hyper-enhancing lesions with non-peripheral washout ranging from 1 to less than 2 cm from LI-RADS 4 to LI-RADS 5.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.